Anhui Heryi Pharmaceutical Co (BJSE:920478) ROCE %: 1.29% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920478 Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
77 GF Score
Price ¥12.30
GF Value ¥10.49
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Anhui Heryi Pharmaceutical Co ROCE %?

Anhui Heryi Pharmaceutical Co BJSE:920478 77 ROCE % is 1.29% as of Mar. 2026. GuruFocus rates BJSE:920478 with a GF Score™ of 77/100 and a GF Value™ of ¥10.49 (Modestly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Anhui Heryi Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.29%.

Anhui Heryi Pharmaceutical Co  (BJSE:920478) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Anhui Heryi Pharmaceutical Co ROCE % Related Terms

Anhui Heryi Pharmaceutical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Anhui Heryi Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anhui Heryi Pharmaceutical Co ROCE % Chart

Anhui Heryi Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.43 19.89 12.93 11.08 10.15

Anhui Heryi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.77 20.75 2.63 2.22 1.29
BJSE:920478
77GF Score
Anhui Heryi Pharmaceutical Co Ltd BJSE:920478
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anhui Heryi Pharmaceutical Co ROCE % Calculation

Anhui Heryi Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=53.751/( ( (561.586 - 64.385) + (637.254 - 74.895) )/ 2 )
=53.751/( (497.201+562.359)/ 2 )
=53.751/529.78
=10.15 %

Anhui Heryi Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=7.424/( ( (637.254 - 74.895) + (647.895 - 61.793) )/ 2 )
=7.424/( ( 562.359 + 586.102 )/ 2 )
=7.424/574.2305
=1.29 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.29% mean?
Anhui Heryi Pharmaceutical Co (BJSE:920478) has a ROCE % of 1.29% as of Mar. 2026.
Is Anhui Heryi Pharmaceutical Co's ROCE % too high?
Anhui Heryi Pharmaceutical Co's current ROCE % is 1.29%. The Drug Manufacturers industry median ROCE % is 6.91. Anhui Heryi Pharmaceutical Co's value of 1.29% is 81.3% below this industry median. Overall, Anhui Heryi Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anhui Heryi Pharmaceutical Co's ROCE % compare to ZTS?
Anhui Heryi Pharmaceutical Co's ROCE % of 1.29% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 6.91. Anhui Heryi Pharmaceutical Co's value of 1.29% is 81.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 6.91, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anhui Heryi Pharmaceutical Co's current ROCE % of 1.29% is 81.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 6.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anhui Heryi Pharmaceutical Co's current ROCE % is 1.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anhui Heryi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Anhui Heryi Pharmaceutical Co (BJSE:920478) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥10.49, compared to a current price of ¥12.30 — trading 17.3% above its estimated fair value. The current ROCE % is 1.29% and 81.3% below the Drug Manufacturers industry median of 6.91. Anhui Heryi Pharmaceutical Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Anhui Heryi Pharmaceutical Co (BJSE:920478), the current ROCE % is 1.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Anhui Heryi Pharmaceutical Co (BJSE:920478) Overvalued in 2026?

Based on GuruFocus' analysis, Anhui Heryi Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥12.30 is trading 17.3% above its estimated GF Value™ of ¥10.49. GuruFocus considers Anhui Heryi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920478:

  • ROCE %: 1.29%
  • GF Value™: ¥10.49 vs. price of ¥12.30 (17.3% above fair value)
  • GF Score™: 77/100 with 6 warning signs
  • Industry Position: 81.3% below the Drug Manufacturers median

No single metric tells the full story. See the BJSE:920478 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anhui Heryi Pharmaceutical Co Business Description

Address Yangcun Industrial Park, Anhui Province, Tianchang City, CHN, 239304
Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.
77GF Score

Get the complete analysis for BJSE:920478

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.30
Price
¥10.49
GF Value